SwissHealth Ventures
Overview
SwissHealth Ventures is the corporate venture capital arm of CSS Insurance, Switzerland's leading health insurer, that invests in start-ups with a focus on digital health, health technology, and information technology within Europe.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Kranus Health | Mar 2024 | Series A Extension | Co-investor |
| Oska Health | Feb 2026 | Seed | Lead |
| Heartbeat Medical | Apr 2022 | Strategic | Lead |
| deepc | Jul 2024 | Series A Extension | Co-investor |
| Entyre | Jan 2022 | Series A | Co-investor |
For institutional investors. Book with your work email.
Key People
Markus Rommel
Principal
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is SwissHealth Ventures based?
SwissHealth Ventures is headquartered in Lucerne, United States.
When was SwissHealth Ventures founded?
SwissHealth Ventures was founded in 2020.
How many portfolio companies does SwissHealth Ventures have?
SwissHealth Ventures has 7 portfolio companies in Caplight's dataset.
What are some companies in SwissHealth Ventures's portfolio?
Portfolio companies visible on Caplight include Kranus Health, Oska Health, Heartbeat Medical, deepc, Entyre.
What was SwissHealth Ventures's most recent investment shown here?
SwissHealth Ventures's most recent investment in this portfolio sample was in Oska Health in 2026.
What sectors does SwissHealth Ventures focus on?
SwissHealth Ventures focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Consumer & Commerce, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Enterprise Software, Healthcare & Life Sciences, Enterprise Software, Consumer & Commerce, Enterprise Software.
What company stages does SwissHealth Ventures focus on?
SwissHealth Ventures typically invests at the Early stage.
What is SwissHealth Ventures's AUM?
SwissHealth Ventures's assets under management are estimated between $56.0M and $56.0M.